Gabriele Pitingolo

Dr. Gabriele Pitingolo

Ecole Normale Superieure in Paris
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2016 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
AFAndrea P. Falanga
Andrea P. Falanga
Gabriele PitingoloGabriele Pitingolo
Gabriele Pitingolo
MCMaurizio Celentano
Maurizio Celentano
ACArmando Cosentino
Armando Cosentino
PMPietro Melone
Pietro Melone
PNPaolo Netti
Paolo Netti

6 May 2016 in Biofabrication
Verified
Journal Article
Closed access
PDF file
Raffaele VecchioneRaffaele Vecchione
Raffaele Vecchione
Gabriele PitingoloGabriele Pitingolo
Gabriele Pitingolo
DGDaniela Guarnieri
Daniela Guarnieri
AFAndrea P Falanga
Andrea P Falanga
PNPaolo Netti
Paolo Netti
Square microchannels are easy to fabricate by means of micromachining or lithographic techniques. However, in vitro vascular microcapillaries—as well as plug production and microparticle alignment—require mainly circular microchannels that can be used also in applications based on open microchannels. Nowadays, a simple, low cost, and versatile method to fabricate circular microchannels is still missing. Here, we report on a fast, inexpensive, flexible and reproducible method to fabricate circular microchannels by coupling spin coating with micromilled square microchannels. The proposed method is based on the balance between the displacement of liquid PDMS induced by centrifugal forces and the surface tension that tends to keep the liquid accumulated especially in the corners, which become therefore rounded. To show the versatility of the described experimental study we prepared a variety of rounded microchannels, including branched and PMMA–PDMS hybrid configuration microchannels. Finally, an endothelial cell layer was formed by culturing brain endothelial bEnd.3 cells inside the proposed circular microchannels. Results demonstrated a more successful adhesion, growth, and homogeneous distribution of the cells along the circular microchannel than those observed in the square microchannel used as a control.

1 November 2018 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
Gabriele PitingoloGabriele Pitingolo
Gabriele Pitingolo
PNPhilippe Nizard
Philippe Nizard
ARAntoine Riaud
Antoine Riaud
VTValérie Taly
Valérie Taly

27 January 2022
Verified
Book Chapter
Closed access
MRMaria Russo
Maria Russo
CCCesare M Cejas
Cesare M Cejas
Gabriele PitingoloGabriele Pitingolo
Gabriele Pitingolo

29 May 2019 in Advanced Engineering Materials
Verified
Journal Article
Closed access
PDF file
Gabriele PitingoloGabriele Pitingolo
Gabriele Pitingolo
ARAntoine Riaud
Antoine Riaud
CNClaudio Nastruzzi
Claudio Nastruzzi
VTValérie Taly
Valérie Taly

11 June 2021 in Bioconjugate Chemistry
Verified
Journal Article
Open access
CNConcetta Di Natale
Concetta Di Natale
EBEdmondo Battista
Edmondo Battista
VLVincenzo Lettera
Vincenzo Lettera
NRNarayana Reddy
Narayana Reddy
Gabriele PitingoloGabriele Pitingolo
Gabriele Pitingolo
PNPaolo Antonio Netti
Paolo Antonio Netti
The development of assays for protein biomarkers in complex matrices is a demanding task that still needs implementation of new approaches. Antibodies as capture agents have been largely used in bioassays but their low stability, low-efficiency production, and cross-reactivity in multiplex approaches impairs their larger applications. Instead, synthetic peptides, even with higher stability and easily adapted amino acid sequences, still remain largely unexplored in this field. Here, we provide a proof-of-concept of a microfluidic device for direct detection of biomarker overexpression. The multichannel microfluidic polydimethylsiloxane (PDMS) device was first derivatized with PAA (poly(acrylic acid)) solution. CRP-1, VEGF-114, and ΦG6 peptides were preliminarily tested to respectively bind the biomarkers, C-reactive protein (CRP), vascular endothelial growth factor (VEGF), and tumor necrosis factor-alpha (TNF-α). Each PDMS microchannel was then respectively bioconjugated with a specific peptide (CRP-1, VEGF-114, or ΦG6) to specifically capture CRP, VEGF, and TNF-α. With such microdevices, a fluorescence bioassay has been set up with sensitivity in the nanomolar range, both in buffered solution and in human serum. The proposed multiplex assay worked with a low amount of sample (25 μL) and detected biomarker overexpression (above nM concentration), representing a noninvasive and inexpensive screening platform.